Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Sydney
Clinical trial register · Australia

Clinical Trials in Sydney, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3370 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
3370
Studies in scope
all four open statuses
1816
Recruiting now
open to new participants
776
Lead sponsors
across recruiting studies
Top sites
Melbourne 1109 Adelaide 582 Sydney 520 Westmead 421 Clayton 411
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC17 Kirby Institute10 The George Institute9 Eli Lilly and Company9 Australian and New Zealand Intensive Care Research Centre9 Novartis Pharmaceuticals9 Sanofi7 Gilead Sciences6 University of Sydney6 Incyte Corporation6 Peter MacCallum Cancer Centre, Australia6 Western Sydney Local Health District5 Melanoma and Skin Cancer Trials Limited4 University of Birmingham4 Australasian Gastro-Intestinal Trials Group4 University of Melbourne4 St Vincent's Hospital, Sydney4 Hoffmann-La Roche4 ViiV Healthcare4 Exelixis4 Bristol-Myers Squibb4 Region Skane3 Novo Nordisk A/S3 Melanoma Institute Australia3 Genmab3 Telix Pharmaceuticals (Innovations) Pty Limited3 Atridia Pty Ltd.3 AstraZeneca3 Zimmer Biomet3 Verastem, Inc.3 Cochlear3 Janssen Research & Development, LLC3 Jiangsu HengRui Medicine Co., Ltd.3 Takeda3 The University of Queensland3 Daiichi Sankyo3 DualityBio Inc.3 Olivia Newton-John Cancer Research Institute3 Kite, A Gilead Company3 Bayer3 AbbVie3 Pfizer3 Alkermes, Inc.3 South West Sydney Local Health District3 IDEAYA Biosciences3 Murdoch Childrens Research Institute3 Chugai Pharmaceutical2 Lubris Bio Pty Ltd2 GlaxoSmithKline2 argenx2 Clinical Hub for Interventional Research (CHOIR)2 Kailera2 BioNTech SE2 Innovent Biologics (Suzhou) Co. Ltd.2 Immunovant Sciences GmbH2 Abbott Medical Devices2 University of Calgary2 Amgen2 ADARx Pharmaceuticals, Inc.2 Avalyn Pharma Inc.2 Celgene2 Kiora Pharmaceuticals, Inc.2 Sydney Local Health District2 Neuroscience Research Australia2 Arrowhead Pharmaceuticals2 Hummingbird Bioscience2 Sydney Children's Hospitals Network2 Kivu Bioscience Inc.2 Australian & New Zealand Children's Haematology/Oncology Group2 Neurotech Pharmaceuticals2 Surgical Outcomes Research Centre (SOuRCe)2 Olema Pharmaceuticals, Inc.2 Sitala Bio LTD2 HighLife SAS2 EyeBiotech Ltd.2 European Myeloma Network B.V.2 The University of New South Wales2 Monash University2 PYC Therapeutics2 EMD Serono Research & Development Institute, Inc.2 Priovant Therapeutics, Inc.2 Woolcock Institute of Medical Research2 Multitude Therapeutics Inc.2 ResMed2 University Health Network, Toronto2 Regeneron Pharmaceuticals2 Alcon Research2 D3 Bio (Wuxi) Co., Ltd2 Stichting Hemato-Oncologie voor Volwassenen Nederland2 Vantage Biosciences Ltd1 Wake Forest University1 Morten H. Bestle1 Arcus Biosciences, Inc.1 W.L.Gore & Associates1 Dimerix Bioscience Pty Ltd1 Supernus Pharmaceuticals, Inc.1 University Hospital Birmingham NHS Foundation Trust1 Perceive Biotherapeutics, Inc.1 Ladera Medical1 Pharmacyclics Switzerland GmbH1 Antengene Therapeutics Limited1 Sabine Mueller, MD, PhD1 Ingenia Therapeutics INC1 Sirnaomics1 ORIC Pharmaceuticals1 Kither Biotech Srl1 Mario Negri Institute for Pharmacological Research1 Verve Therapeutics, Inc.1 Indiana University1 Lakefront Biotherapeutics West LLC1 Washington University School of Medicine1 CorWave1 Penumbra Inc.1 Nkarta, Inc.1 University of Oxford1 Grey Wolf Therapeutics1 Professor Michael Bourke1 Beijing InnoCare Pharma Tech Co., Ltd.1 Arovella Therapeutics Ltd1 Imviva Bio1 TR Therapeutics1 Damora Therapeutics1 VZW Cardiovascular Research Center Aalst1 University Medical Center Nijmegen1 Massachusetts General Hospital1 ImmuneSensor Therapeutics Inc.1 Neurogene Inc.1 The Netherlands Cancer Institute1 Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)1 Eikon Therapeutics1 Pulmovant, Inc.1 Helsinki University Central Hospital1 Auckland City Hospital1 Smith & Nephew, Inc.1 Vega Therapeutics, Inc1 Disc Medicine, Inc1 University of Milano Bicocca1 CSL Behring1 Amplitude Vascular Systems, Inc.1 4D Molecular Therapeutics1 Spark Therapeutics, Inc.1 Genzyme, a Sanofi Company1 University of Minnesota1 CStone Pharmaceuticals1 The Lowy Medical Research Institute Limited1 Design Therapeutics, Inc.1 Universitätsklinikum Hamburg-Eppendorf1 University Medical Center Groningen1 The POLG Foundation1 University of Kansas Medical Center1 Vicore Pharma AB1 BioMarin Pharmaceutical1 Uniquity One (UNI)1 Annexon, Inc.1 Dragonfly Therapeutics1 MOMA Therapeutics1 Klotho Sciences Australia Pty Ltd.1 AO Innovation Translation Center1 XYone Therapeutics, Inc1 Sanofi Pasteur, a Sanofi Company1 Therapeutic Advances in Childhood Leukemia Consortium1 Medtronic MiniMed, Inc.1 Spinogenix1 Bond Biosciences1 Pierre Fabre Medicament1 IO Biotech1 Rapport Therapeutics Inc.1 The University of Texas Health Science Center, Houston1 Janssen Scientific Affairs, LLC1 Philips Clinical & Medical Affairs Global1 Garvan Institute of Medical Research1 Pauline Kang1 St. Anna Kinderkrebsforschung1 Cloudbreak Therapeutics, LLC1 Betta Pharmaceuticals Co., Ltd.1 VDyne, Inc.1 Centers for Disease Control and Prevention1 Science Corporation1 Northern Sydney and Central Coast Area Health Service1 Filamon LTD1 Biojiva LLC1 Avecho Biotechnology1 Full-Life Technologies UK Limited1 Universitaire Ziekenhuizen KU Leuven1 Jubilant Therapeutics Inc.1 TRIANA Biomedicines, Inc.1 Myopharm Limited1 Tectonic Therapeutic1 Zydus Therapeutics Inc.1 European Organisation for Research and Treatment of Cancer - EORTC1 SK Bioscience Co., Ltd.1 Ipsen1 Stemline Therapeutics, Inc.1 Epicrispr Biotechnologies, Inc.1 Royal Hospital For Women1 European Foundation for Study of Chronic Liver Failure1 Myeloid Therapeutics1 Prostate Cancer Clinical Trials Consortium1 Genetix Biotherapeutics Inc.1 Cerevance1 Medacta International SA1 Laekna Limited1 Genentech, Inc.1 Amsterdam UMC, location VUmc1 University of Edinburgh1 Memorial Sloan Kettering Cancer Center1 Queensland Centre for Gynaecological Cancer1 University of Aarhus1 Ansun Biopharma, Inc.1 University of Auckland, New Zealand1 DBV Technologies1 Martin Schrappe1 Dianthus Therapeutics1 Princess Maxima Center for Pediatric Oncology1 Theratocular Biotek Co.1 Relay Therapeutics, Inc.1 Texas A&M University1 Kyowa Kirin Co., Ltd.1 Ryme Medical, Inc.1 OncoBeta Therapeutics1 Anna Erenbourg1 Medicenna Therapeutics, Inc.1 BioCryst Pharmaceuticals1 pharmaand GmbH1 Meiji Pharma USA Inc.1 Revolution Medicines, Inc.1 Australian and New Zealand Urogenital and Prostate Cancer Trials Group1 Bright Minds Biosciences Pty Ltd1 United Therapeutics1 Tortugas Neuroscience, Inc.1 University of Iowa1 Medinol Ltd.1 Bioventus LLC1 Lumara Bio Oncologics GmbH1 Nyxoah S.A.1 Merit Medical Systems, Inc.1 AVEO Pharmaceuticals, Inc.1 National Institute of Allergy and Infectious Diseases (NIAID)1 VividWhite Pty Ltd1 BellaSeno Pty Ltd1 Corvia Medical1 Victor Chang Cardiac Research Institute1 Gustave Roussy, Cancer Campus, Grand Paris1 Hospital Universitari de Bellvitge1 Chinese University of Hong Kong1 Servier Affaires Médicales1 Celosia Therapeutics Pty Ltd1 Absci Pty Ltd.1 Caravel Oculus Pty Ltd1 Seagen, a wholly owned subsidiary of Pfizer1 Children's Hospital of Philadelphia1 Therini Bio Pty Ltd1 Beacon Therapeutics1 Nuvalent Inc.1 Iksuda Therapeutics Ltd.1 Menicon Co., Ltd.1 Medtronic Cardiovascular1 Trans Tasman Radiation Oncology Group1 Perminder Sachdev1 Shanghai Junshi Bioscience Co., Ltd.1 Caranx Medical1 Teligene US1 Oticara Australia PTY LTD1 Amsterdam UMC1 Anthony Joshua, FRACP1 Eupraxia Pharmaceuticals Inc.1 Solid Biosciences Inc.1 Zynerba Pharmaceuticals, Inc.1 Boston Scientific Corporation1 Swedish Orphan Biovitrum1 Boehringer Ingelheim1 Actio Biosciences, Inc.1 XII Medical1 National Eye Institute (NEI)1 Biotronik SE & Co. KG1 Adlai Nortye Biopharma Co., Ltd.1 Epkin1 Austin Health1 Basilea Pharmaceutica1 Benobio Co., Ltd.1 Shanghai Allink Biotherapeutics Co., Ltd.1 EtiraRx Australia Pty Ltd1 University of Pennsylvania1 Michael Shy1 Woolsey Pharmaceuticals1 Taiho Oncology, Inc.1 Acerta Pharma BV1 Adcytherix SAS1 Clarity Pharmaceuticals Ltd1 Columbia University1 ALX Oncology Inc.1 Shandong Suncadia Medicine Co., Ltd.1 University of California, San Francisco1 AO Foundation, AO Spine1 QBiotics Group Limited1 Jazz Pharmaceuticals1 Yuhan Corporation1 Efemoral Medical, Inc.1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 iECURE, Inc.1 Pleryon Therapeutics (Hangzhou) Limited1 Taiho Pharmaceutical Co., Ltd.1 Laboratoires Thea1 Multitude Therapeutics (Australia) Pty Ltd1 Second Life Therapeutics1 University Hospital, Basel, Switzerland1 Pharvaris Netherlands B.V.1 Institut de Recherches Internationales Servier (I.R.I.S.)1 ImmVirx Pty Ltd1 DynamiCure Biotechnology1 Uppsala University1 University Medical Centre Ljubljana1 Akeso1
Site location
Melbourne1109 Adelaide582 Sydney520 Westmead421 Clayton411 Nedlands381 Brisbane355 Camperdown348 Parkville320 South Brisbane313 Perth299 Heidelberg273 Darlinghurst246 Woolloongabba239 Randwick210 St Leonards198 Liverpool195 Murdoch188 Fitzroy176 Kogarah162 Box Hill157 Southport154 Bedford Park154 Wollongong149 Herston143 Waratah136 Concord123 East Melbourne118 Frankston117 Birtinya116 Blacktown112 Hobart108 Chermside84 Gosford81 Garran78 Macquarie Park75 Kingswood74 Malvern73 Geelong72 Saint Leonards67 Auchenflower67 New Lambton Heights62 Newcastle62 Douglas57 Campbelltown53 Kurralta Park51 Elizabeth Vale51 Albury50 St Albans50 North Adelaide49 Camberwell49 Coffs Harbour48 Macquarie University48 Greenslopes47 Richmond44 Subiaco43 Port Macquarie41 Woodville South41 Maroochydore39 North Ryde39 Botany39 Wahroonga38 Benowa37 Canberra37 Ballarat36 Carlton32 Cairns30 Wollstonecraft30 Charlestown29 Townsville29 Orange29 Epping25 North Sydney24 Woodville23 Hunter Regional Mail Centre23 Bendigo21 Miranda21 Hurstville19 Bankstown19 Bayswater19 Saint Albans19 Parramatta18 Gold Coast18 Buderim17 Footscray17 Joondalup17 Ivanhoe16 Penrith16 Morayfield16 Launceston16 Fremantle16 Sippy Downs15 Broadmeadow15 Ballarat Central15 Gateshead15 Coorparoo15 West Perth15 Toowoomba14 Spearwood13 Ipswich13 Merewether13 Maroubra12 Tugun12 Frenchs Forest12 Sunshine Coast12 New Lambton12 Kanwal11 Bundaberg11 Lismore11 Strathfield11 Darwin10 Macquarie10 Milton10 Traralgon10 Taringa10 Tweed Heads10 Brookvale10 Hyde Park10 Mitcham10 Waitara10 Shepparton9 South Yarra9 Bruce9 Victoria Park9 Fitzroy Melbourne9 Norwood9 Tiwi9 Oaklands Park9 Phillip9 Bowral9 Leabrook9 Heidelberg West8 Castle Hill8 North Melbourne8 Midland8 Caulfield South8 Mackay8 Wagga Wagga8 Meadowbrook8 Melbourne N.8 Nowra7 Surry Hills7 Heidelberg Heights7 Dubbo7 Prahran7 Kotara7 Cudgen7 Fortitude Valley6 Deakin6 North Tamworth6 Wayville6 Chelmer6 New South Wales6 Burwood5 Wendouree5 Bedford PK5 Wooloongabba5 East Bentleigh5 Rowville5 Warrnambool4 Windsor Gardens4 North Terrace4 Cooloongup4 Spring Hill4 Hervey Bay4 Caringbah4 East Albury4 Queensland4 Bella Vista4 Newtown4 Mount Kuring-Gai4 Wodonga4 Rockhampton4 Mount Waverley4 Chatswood4 Wentworthville4 Crawley4 Maribyrnong4 Hoppers Crossing4 Redcliffe4 Torquay4 Reservoir4 Gosford NSW3 Osborne Park3 Melbourne E.3 Albion3 Urraween3 Mount Pleasant3 Victoria3 North Mackay3 Tarragindi3 Mulgrave3 South Woodville3 Ryde3 Windsor3 Nambour3 Alexandria3 Ashford3 Erina3 Lambton Heights3 Kent Town3 Prahan3 Murdock3 North Altona3 Caboolture3 Bowen Hills3 Noosa3 Waratah NSW3 Altona N.3 Toorak Gardens3 Eastwood3 East Toowoomba2 East Maitland2 Multiple Locations2 Saint Hobart2 Northcote2 Kurraba Point2 Macquarie Island2 Monash2 Warrawong2 Parkville VIC2 Parkville Melbourne2 Broome2 West Mackay2 Moorabbin2 Burnie2 Northmead2 Hamlyn Terrace2 Baulkham Hills2 Gympie2 Notting Hill2 Kelvin Grove2 Bunbury2 Leichhardt2 Stepney2 Clayfield2 Griffith2 Claremont2 Berwick2 Chemside2 Brighton2 Camperdown, Sydney2 Bentleigh East2 South Perth2 Auburn2 Colac1 Wallan1 Herston (rbwh Grounds)1 Rockingham1 Bruse1 Pyrmont1 Wyong1 Beverly Hills1 Morphett Vale1 East Perth1 Abbotsford1 Leederville1 Frankston East1 Capel Sound1 Hong Kong1 Richmon1 Kalgoorlie-Boulder1 Annerley1 Langwarrin1 Pialba1 Warners Bay1 Doncaster1 Royal Prince Alfred Hospital1 Franston1 Adelaie1 Albany1 Australia1 Woden1 Kippa-Ring1 Palmyra Dc1 Glebe1 Franskton1 Bentley1 Mount Gambier1 Rosslea1 Aldershot1 Rathdowney1 Heidelberg,VIC1 Hunter Region, NSW1 Darlinghurst, Sydney1 Kew1 Ararat1 Beaufort1 Daylesford1 Maryborough1 Nhill1 Saint Arnaud1 Warracknabeal1 Parkdale1 QLD1 Hornsby1 Wantirna1 Auckland1 Daw Park1 Geebung1 Logan1 Aberfoyle Park1 East Gosford1 Griffith University1 Carlton North1 St Kilda1 Cairns North1 Craigie1 Saint Leonards,1 Pymble1 Bondi Junction1 Lane Cove1 Joondalup WA1 Concord West1 Lambton1 Mount Waverly1 Greenfields1 Bakewell1 Palmerston1 Maitland1 Taree1 Syndey1 Potts Point1 Cleveland1 Dunedin1 Cheltenham1 Halls Creek1 Hurstville, Sydney1 Norwest1 Charleston1 Woolloongab1 Hope Island1 Bundoora1 Chandler1 Moonee Ponds1 Mount Druitt1 Coopers Plains1 Newstead1 Waurn Ponds1 Old Toongabie1 Blactown1 Double Bay1 Everton Park1 Doncaster East1 Vermont South1 Parkwood1 Coburg1 Helensvale1 Woolloongabba, QLD1 South Australia1 North Ballarat1 Ringwood1 City of Burnside1 Raymond Terrace1 Woodford1 Albans1 Tamworth1 Hillsdale1 Campsie1 Mornington1 Hawthorn1 Caloundra1 Dee Why1 Craigieburn1 Glenroy1 Melton South1 Sunshine1 Werribee1 Woolangabba1 Woollangabba1 Alice Springs1 Chermside Brisbane1 Woodville South, Adelaid1 Melbourne, VIC1 Wellers Hill1 Glen Iris1 Cessnock1 Grafton1 Douglass1 Wembley1 Coolangatta1 Nundah1 Robina1 Concors1 North Mackey1 Saint Lucia1 Sutherland1 Bathurst1 Broken Hill1 Inverell1 Katherine1 Nhulunbuy1 Salzburg1 Vienna1 Hunter1 Cooks Hill1
All 396 locations
Target enrolment
to

Trials with a site in Sydney

520 of 3370 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Massachusetts General Hospital
Phase 1
280
Sydney, Maroochydore, Morayfield, Camberwell
2027-02-03
Not yet open
Olivia Newton-John Cancer Research Institute
Phase 2
25
Sydney, Woolloongabba, Clayton, Heidelberg, Nedlands
2027-01-01
Not yet open
Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections
NCT07858526Serious Gram-Positive Bacterial Infections
DrugDalbavancin
Kirby Institute
Observational
50
Sydney
2027-01-01
Not yet open
STSC-HybridAPC Trial
NCT07682805Colon Adenomas, Colon Adenomatous Polyp
Western Sydney Local Health District
Not applicable
140
Sydney
2027-01-01
Not yet open
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
NCT07739017Recurrent Glioblastoma, Newly Diagnosed MGMT Unmethylated Glioblastoma
Olivia Newton-John Cancer Research Institute
Phase 1
54
Sydney, Brisbane, Herston, Heidelberg, Melbourne
2026-12
Not yet open
Atridia Pty Ltd.
Early Phase 1
101
Sydney, Brisbane, Melbourne
2026-11-15
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Castle Hill, Darlinghurst, Maroubra, Sydney, Douglas, Torquay, Bunbury, Perth
2026-11-11
Not yet open
Swabs in Screening for HPV (SWISH)
NCT07790601Anal Cancer, Human Papilloma Virus (HPV)
Kirby Institute
Not applicable
700
Cudgen, Darlinghurst, Sydney, Adelaide, Melbourne
2026-11-01
Not yet open
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
900
Sydney
2026-10-30
Recruiting
Arovella Therapeutics Ltd
Phase 1
46
Sydney, Brisbane, Adelaide, Melbourne, Richmond
2026-10-19
Recruiting
The George Institute
Phase 3
2,200
Penrith, Sydney, Brisbane, Caboolture, Gold Coast, Adelaide, Melbourne
2026-10-16
Recruiting
Tortugas Neuroscience, Inc.
Phase 2
100
Newcastle, Sydney, Waitara, Southport, Torquay
2026-10-14
Not yet open
Novo Nordisk A/S
Observational
10,000
Sydney
2026-10-13
Not yet open
Baerveldt Versus Paul Study
NCT07733453Glaucoma
University of Sydney
Phase 4
150
Sydney, Melbourne
2026-10-12
Recruiting
Clinical Evaluation of a Novel Trifocal IOL
NCT07587138Aphakia, Cataract
Alcon Research
Not applicable
66
Sydney
2026-10-09
Not yet open
Cochlear
Not applicable
200
Sydney
2026-10
Recruiting
Multitude Therapeutics Inc.
Phase 2/3
512
Coffs Harbour, Melbourne, Newcastle, Sydney
2026-09-30
Recruiting
Biojiva LLC
Phase 1/2
152
Albury, Baulkham Hills, Hurstville, Sydney, East Melbourne, Rowville
2026-09-29
Recruiting
Novartis Pharmaceuticals
Phase 2
259
Sydney, Waitara, Melbourne
2026-09-29
Recruiting
A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression
NCT07686445Solid Tumor (Phase I), RAS Mutation, CEACAM5
Adlai Nortye Biopharma Co., Ltd.
Phase 1
228
Perth, Sydney
2026-09-23
Recruiting
INTERACT4 Expansion - Validation Study
NCT07231315Intracerebral Hemorrhage
The George Institute
Observational
163
Sydney
2026-09-18
Recruiting
Evaluation of XYA02 in Patients With Advanced Solid Tumors
NCT07670312MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer, GEJ Adenocarcinoma
XYone Therapeutics, Inc
Phase 1/2
190
Sydney, Melbourne, Perth
2026-09-17
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Sydney, Westmead, South Brisbane, Adelaide, East Melbourne, Parkville
2026-09-11
Recruiting
Caranx Medical
Not applicable
10
Sydney
2026-09-10
Not yet open
Myopharm Limited
Phase 2
48
Maroochydore, Melbourne, Sydney
2026-09-01
Recruiting
Damora Therapeutics
Phase 1
250
Liverpool, Newcastle, Sydney, Brisbane, Sunshine Coast, Adelaide, Melbourne, Perth
2026-09
Not yet open
Study of Serine Supplementation to Protect Vision in MacTel
NCT07342439Macular Telangiectasia Type 2 (MacTel)
The Lowy Medical Research Institute Limited
Phase 3
120
Sydney, Melbourne
2026-09
Not yet open
First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)
NCT07766473Neovascular (Wet) Age-Related Macular Degeneration
Filamon LTD
Phase 1/2
24
Gosford, Sydney, Westmead, East Melbourne
2026-09
Recruiting
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
NCT07576335Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer, Urinary Incontinence Following Surgical Procedure
DrugTadalafil
Surgical Outcomes Research Centre (SOuRCe)
Phase 2
64
Sydney
2026-08-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
960
Albury, Parramatta, Strathfield, Sydney
2026-08-27
Recruiting
SL-28 for Advanced Solid Tumours
NCT07341737Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic, Lung Adenocarcinoma
Second Life Therapeutics
Phase 1/2
60
Sydney, Gold Coast, Adelaide
2026-08-14
Recruiting
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT07687056Stroke, Acute Ischemic, Endovascular Thrombectomy, Acute Ischemic Stroke AIS
DrugTenecteplase
University of Calgary
Phase 3
1,500
Sydney
2026-08-11
Recruiting
Kither Biotech Srl
Phase 1/2
36
Charlestown, Sydney, Camberwell
2026-08-05
Recruiting
Sitala Bio LTD
Phase 2
15
Newcastle, Penrith, Sydney, Woolloongabba, Clayton, Saint Albans, Perth
2026-08-04
Not yet open
Lubricin-inspired Osteoarthritis Treatment: a Unique Solution
NCT07611708Osteo Arthritis of the Knee
Pleryon Therapeutics (Hangzhou) Limited
Not applicable
25
Sydney
2026-08
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
320
Sydney, Brisbane, Gold Coast, Adelaide, Melbourne
2026-07-30
Recruiting
STP705 Injection for Submental Fat Reduction
NCT07677683Submental Fullness
Sirnaomics
Phase 2
30
Sydney
2026-07-28
Recruiting
A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery
NCT07694375Corneal Endothelial Cell Loss, Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgery
Caravel Oculus Pty Ltd
Phase 2
200
Deakin, Baulkham Hills, Blacktown, Eastwood, Sydney, Adelaide, Hobart, Launceston
2026-07-28
Recruiting
Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
NCT07286292Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
DrugVorasidenib
Institut de Recherches Internationales Servier (I.R.I.S.)
Phase 2
10
Sydney
2026-07-23
Recruiting
Verastem, Inc.
Phase 2
105
Camperdown, Sydney, Brisbane
2026-07-22
Recruiting
Gilead Sciences
Phase 3
590
Surry Hills, Sydney
2026-07-14
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Sydney, Melbourne, Parkville
2026-07-10
Recruiting
Victor Chang Cardiac Research Institute
Phase 2
44
Sydney
2026-07-07
Recruiting
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
NCT07387926Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
DrugsABL001·Hydrocortisone·Blinatumomab·Prednisolone
Novartis Pharmaceuticals
Phase 1/2
50
Sydney
2026-07-05
Not yet open
Oritavancin for Treatment of Serious Cardiac Infections
NCT07550595Infective Endocarditis, Cardiac Device Infection, Gram-positive Bacterial Infections
Kirby Institute
Phase 2
20
Sydney
2026-07-01
Recruiting
ViiV Healthcare
Phase 3
564
Darlinghurst, Sydney, Taringa, Perth
2026-06-25
Recruiting
Taiho Pharmaceutical Co., Ltd.
Phase 3
784
Brisbane, Melbourne, Perth, Sydney
2026-06-24
Recruiting
Novo Nordisk A/S
Phase 2
300
Castle Hill, Charlestown, New Lambton Heights, Sydney, Adelaide, Melbourne
2026-06-22
Recruiting
Prospective Natural History Study of POLG Disease
NCT07775872PolG, Primary Mitochondrial Myopathy
The POLG Foundation
Observational
300
Sydney
2026-06-17
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
NCT07644559Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
DrugsVS-7375·Cetuximab
Verastem, Inc.
Phase 2
185
Sydney, Waratah, Hyde Park, Kurralta Park, Hobart, Melbourne, South Brisbane
2026-06-16
Recruiting
Gilead Sciences
Phase 2
175
Surry Hills, Sydney, South Yarra
2026-06-15
Recruiting
Rapport Therapeutics Inc.
Phase 3
333
Melbourne, Sydney
2026-06-05
Recruiting
Theratocular Biotek Co.
Phase 1/2
31
Hurstville, Sydney, Launceston
2026-06-02
Recruiting
Kivu Bioscience Inc.
Phase 1
76
Sydney, Wollongong, Brisbane
2026-05-25
Active, closed
Kite, A Gilead Company
Phase 3
550
Camperdown, Sydney, East Melbourne
2026-05-22
Recruiting
Takeda
Phase 3
300
Coffs Harbour, Sydney, Waratah, Adelaide, Bedford Park, Clayton, Fitzroy, Heidelberg
2026-05-21
Recruiting
Atridia Pty Ltd.
Phase 1
15
Bowral, Sydney, Elizabeth Vale, Ballarat, Frankston
2026-05-15
Recruiting
Amplitude Vascular Systems, Inc.
Not applicable
15
Sydney, Melbourne
2026-05-08
Recruiting
Bond Biosciences
Phase 1/2
34
Sydney
2026-05-04
Active, closed
Contralateral Claims Study of Clareon Vivity Pro
NCT07484191Aphakia, Presbyopia
Alcon Research
Not applicable
165
Campsie, Sydney, Wollongong, Woolloongabba, East Melbourne, Mornington
2026-04-28
Recruiting
Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
NCT07266584Stargardt Disease, Retinitis Pigmentosa (RP), Inherited Retinal Degeneration
Science Corporation
Not applicable
5
Sydney
2026-04-22
Recruiting
Alkermes, Inc.
Phase 3
176
Sydney
2026-04-22
Recruiting
Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study
NCT07916727Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), Pregnancy
Austin Health
Not applicable
50
Hobart, Melbourne, Sydney
2026-04-15
Recruiting
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
NCT07304154Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis
DrugsKITE-363·Fludarabine·Cyclophosphamide
Kite, A Gilead Company
Phase 1
57
Sydney, Westmead
2026-04-10
Recruiting
Woolcock Institute of Medical Research
Not applicable
40
Sydney
2026-04-10
Not yet open
Peter MacCallum Cancer Centre, Australia
Observational
75
Camperdown, Sydney, Adelaide, Hobart, Box Hill, Clayton, Melbourne, Nedlands
2026-04-08
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
DrugsTiespectus·Eylea·Aflibercept
EyeBiotech Ltd.
Phase 2/3
960
Albury, Hurstville, Hurstville, Sydney, Launceston, Norwest, Parramatta, Strathfield, Sydney
2026-03-27
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580ccRCC, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Renal Cell Cancer Metastatic
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
40
Sydney, Wollongong, Heidelberg, Melbourne N., Murdoch
2026-03-25
Recruiting
RECOMMEND Platform Trial
NCT06526533Extracorporeal Membrane Oxygenation Complication, ARDS (Acute Respiratory Distress Syndrome), Intensive Care Medicine, Cardiac Arrest (CA)
Australian and New Zealand Intensive Care Research Centre
Phase 3
600
Camperdown, Sydney, Melbourne
2026-03-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
Kogarah, Sydney, Frankston, Nedlands
2026-03-23
Recruiting
Meiji Pharma USA Inc.
Phase 1
104
Sydney
2026-03-23
Recruiting
Priovant Therapeutics, Inc.
Phase 2/3
342
Adelaide, Perth, Sydney
2026-03-19
Recruiting
Sanofi
Phase 2/3
526
Sydney, Adelaide, Clayton, Parkville
2026-03-13
Recruiting
Cochlear
Not applicable
20
Sydney
2026-03-12
Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
NCT07491497ALK-positive NSCLC, ALK-Positive Lung Cancer, ALK-positive Non-small Cell Lung Cancer
TRIANA Biomedicines, Inc.
Phase 1/2
160
Sydney, Westmead, Melbourne
2026-03-11
Recruiting
Avalyn Pharma Inc.
Phase 2
160
Camperdown, Kingswood, New Lambton Heights, Sydney, Westmead, Launceston, Heidelberg, Melbourne
2026-03-10
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Sydney, Waitara, Melbourne
2026-03-09
Not yet open
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
42
Sydney
2026-03-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Adelaide, Birtinya, Brisbane, Camperdown, Melbourne, Sydney
2026-03-01
Recruiting
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
NCT07238075Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors
Adcytherix SAS
Phase 1
290
Sydney, Birtinya, Southport, Adelaide, Nedlands
2026-02-23
Recruiting
Scaffold-guided Breast Implant Revision and Primary Breast Augmentation Surgery
NCT07367698Breast Implant Revision, Breast Augmentation Complications, Primary Breast Augmentation Surgery
BellaSeno Pty Ltd
Not applicable
87
Sydney, Brisbane
2026-02-13
Recruiting
ViiV Healthcare
Phase 2
186
Sydney, Clayton, Melbourne
2026-02-11
Recruiting
AO Foundation, AO Spine
Observational
260
Sydney
2026-02-09
Active, closed
Medtronic MiniMed, Inc.
Not applicable
389
New Lambton, Sydney, Perth
2026-02-02
Recruiting
St Vincent's Hospital, Sydney
Phase 1
8
Sydney, Melbourne
2026-02-01
Recruiting
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NCT07399977Venous Thromboembolism, Deep Venous Thrombosis
Memorial Sloan Kettering Cancer Center
Not applicable
259
Sydney
2026-01-30
Recruiting
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT07435038Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
120
Blacktown, Randwick, Sydney, Bedford Park, Heidelberg, Nedlands
2026-01-29
Active, closed
SK Bioscience Co., Ltd.
Phase 1/2
368
Sydney, Joondalup, Nedlands
2026-01-28
By invitation
Immunovant Sciences GmbH
Phase 2
372
South Brisbane, Southport, Perth, St Leonards, Sydney
2026-01-26
Recruiting
Boehringer Ingelheim
Phase 3
400
Bedford Park, Subiaco, Heidelberg, Sydney, Woolloongabba
2026-01-16
Not yet open
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
NCT07292519Alcohol Use Disorder (AUD), Overweight or Obese, Comorbidities and Coexisting Conditions
DrugTirzepatide
South West Sydney Local Health District
Phase 2
46
Sydney
2026-01-15
Recruiting
ImmuneSensor Therapeutics Inc.
Phase 1
6
Sydney
2026-01-12
Recruiting
A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults
NCT07232121Healthy Participants, Healthy Adult Females, Healthy Adult Male, Healthy
Dragonfly Therapeutics
Phase 1
48
Sydney
2026-01-12
Active, closed
Kailera
Phase 3
1,270
Bruce, Blacktown, Charlestown, Kanwal, Leichhardt, Penrith, Sydney, Wollongong
2026-01-12
Recruiting
Celosia Therapeutics Pty Ltd
Phase 1
15
Sydney
2026-01-12
Recruiting
Incyte Corporation
Phase 1
280
Sydney, Woolloongabba, Adelaide, Melbourne
2026-01-08
Not yet open
Bright Minds Biosciences Pty Ltd
Phase 2
16
Sydney, Melbourne
2026-01
Recruiting
Laekna Limited
Phase 1
104
Sydney, Brisbane
2025-12-30
Recruiting
Sanofi
Phase 2
144
Sydney, Woodville, South Perth
2025-12-29
Active, closed
Kailera
Phase 3
2,530
Charlestown, Sydney, Wollongong, Sippy Downs, Norwood, Heidelberg Heights, Melbourne
2025-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 1
250
Sydney, Clayton, Melbourne, Nedlands
2025-12-16
Not yet open
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
NCT07247370Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD), Comorbidities and Coexisting Conditions
DrugKetamine
South West Sydney Local Health District
Phase 1/2
20
Sydney
2025-12-10
Recruiting
BioNTech SE
Phase 2
105
Bedford Park, Benowa, Frankston, Melbourne, Mount Pleasant, Saint Leonards, Sunshine Coast, Sydney
2025-12-04
Recruiting
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia
NCT07317544Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female
Absci Pty Ltd.
Phase 1/2
227
Sydney, Brisbane, Melbourne, South Perth
2025-12-03
Recruiting
St Vincent's Hospital, Sydney
Not applicable
24
Sydney
2025-12-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Sydney
2025-11-26
Recruiting
Neurotech Pharmaceuticals
Phase 4
234
East Melbourne, Perth, Sydney
2025-11-21
Recruiting
AbbVie
Phase 2
400
Kogarah, Sydney, Auchenflower, Adelaide, Hobart, Clayton, Geelong, Melbourne
2025-11-13
Recruiting
Kivu Bioscience Inc.
Phase 1
76
Camperdown, Sydney, Brisbane, Adelaide, Geelong
2025-11-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
996
Maroubra, Sydney, Taringa, Norwood, Camberwell, Hoppers Crossing
2025-11-11
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Albury, Hurstville, Parramatta, Sutherland, Sydney, East Melbourne, Rowville, Malvern
2025-11-10
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Sydney, Waratah, South Brisbane, Adelaide, Clayton, Geelong, Heidelberg, Nedlands
2025-11-03
Not yet open
Nyxoah S.A.
Observational
39
Sydney, Brisbane, Melbourne, Perth
2025-11
Recruiting
Ingenia Therapeutics INC
Phase 1/2
94
Herston, Gosford, Sydney, Morayfield, Saint Albans
2025-10-30
Recruiting
Neuroscience Research Australia
Not applicable
258
Sydney
2025-10-30
Recruiting
Solid Biosciences Inc.
Phase 3
80
Sydney
2025-10-22
Recruiting
Vega Therapeutics, Inc
Phase 3
60
Sydney, Brisbane, Melbourne
2025-10-15
Recruiting
PRIORITY-CONNECT 2 Trial
NCT06976710Colorectal Cancer, Colorectal Neoplasms
Surgical Outcomes Research Centre (SOuRCe)
Not applicable
564
Coffs Harbour, Newcastle, Sydney, Wagga Wagga, Wollongong, Brisbane, Adelaide, Ballarat
2025-10-15
Recruiting
Sanofi
Phase 1/2
104
Sydney, Adelaide, East Melbourne
2025-10-09
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Sydney, North Adelaide
2025-10-09
Recruiting
A Study of CTD402 in T-ALL/LBL Patients
NCT07070219Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
Imviva Bio
Phase 1/2
118
Sydney
2025-10-07
Recruiting
Incyte Corporation
Phase 1
120
Sydney, Adelaide, Melbourne, Nedlands
2025-10-01
Recruiting
Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)
NCT06970106OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies, Kjer Optic Atrophy
DrugPYC-001
PYC Therapeutics
Phase 1/2
24
Sydney, East Melbourne
2025-09-30
Recruiting
Lubris Bio Pty Ltd
Phase 2
80
Sydney, Brisbane, Maroochydore, Melbourne
2025-09-17
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Caulfield South, Sydney, Southport
2025-09-17
Recruiting
Lubris Bio Pty Ltd
Phase 2
15
Sydney, Brisbane, Melbourne
2025-09-17
Recruiting
ResMed
Observational
800
Sydney
2025-09-15
Recruiting
Peter MacCallum Cancer Centre, Australia
Observational
80
Sydney, Brisbane, Cairns, Melbourne
2025-09-11
Not yet open
A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers
NCT07143331Healthy Participants, Alzheimer Disease, Chronic Kidney Disease
Klotho Sciences Australia Pty Ltd.
Phase 1
84
Sydney
2025-08-30
Recruiting
Kiora Pharmaceuticals, Inc.
Phase 2
36
Sydney, Woolloongabba, Adelaide, East Melbourne, Nedlands
2025-08-29
Not yet open
The George Institute
Not applicable
120
Sydney
2025-08-28
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Liverpool, Wollongong, Sydney, Woolloongabba
2025-08-28
Recruiting
Actio Biosciences, Inc.
Phase 1
92
Sydney
2025-08-28
Recruiting
University of Minnesota
Observational
1,500
Camperdown, Sydney, Westmead, Brisbane, Clayton, Heidelberg, Melbourne, Parkville
2025-08-25
Active, closed
PSMA PET Combined With MRI for the Detection of PCa
NCT07052214PCA, Prostate Cancer, Prostatic Neoplasm, PSMA PET
DrugIlluccix
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
338
Melbourne N., Sydney
2025-08-18
Active, closed
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
NCT07122661Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus, Lower Respiratory Tract Disease, Respiratory Tract Diseases
DrugsAbrysvo·RSVpreF
Pfizer
Observational
1
Sydney
2025-08-11
Recruiting
OM336 in Autoimmune Cytopenias
NCT07083960AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia, ITP - Immune Thrombocytopenia
Lakefront Biotherapeutics West LLC
Phase 1
32
Canberra, Sydney, Brisbane
2025-08-01
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
NCT07047703Axial Spondyloarthritis (AxSpA)
Grey Wolf Therapeutics
Phase 1/2
140
Birtinya, Morayfield, Perth, Sydney
2025-07-28
Recruiting
Pfizer
Phase 3
714
Coffs Harbour, North Ryde, Sydney, Birtinya, Douglas, Gympie, Nambour, Woolloongabba
2025-07-23
Recruiting
4D Molecular Therapeutics
Phase 3
480
Adelaide, Albury, Strathfield, Sydney
2025-07-22
Recruiting
Daiichi Sankyo
Phase 2
130
Adelaide, Australia, Darlinghurst, Melbourne, Perth, Southport, Sydney
2025-07-18
Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT06974110Advanced Solid Tumor, Metastatic Solid Tumor, Endometrial Cancer, MSI-H Cancer
DrugIrinotecan
MOMA Therapeutics
Phase 1
132
Sydney, Westmead, Woolloongabba, Adelaide, Clayton, Perth
2025-07-16
Active, closed
European Myeloma Network B.V.
Phase 2
30
Adelaide, Sydney
2025-07-02
Recruiting
Akeso
Phase 1
48
Sydney
2025-07-02
Not yet open
Menicon Co., Ltd.
Not applicable
220
Hillsdale, Sydney, Kelvin Grove, Carlton
2025-07-01
Recruiting
Benobio Co., Ltd.
Phase 1
18
Sydney
2025-07-01
Recruiting
Neuroscience Research Australia
Not applicable
392
Sydney
2025-06-26
Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT07020221Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer, Colorectal Cancer, Solid Tumor, Adult
DrugsVS-7375·Repaglinide·Defactinib·Erbitux
Verastem, Inc.
Phase 1/2
616
Sydney, Frankston
2025-06-24
Recruiting
XII Medical
Not applicable
30
Canberra, Sydney, Wollongong, Brisbane, Perth
2025-06-24
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Sydney, Warrawong, Brisbane, Douglas, Southport, Box Hill, Geelong, Parkville
2025-06-19
Active, closed
Atridia Pty Ltd.
Phase 1
25
Sydney, Adelaide, Brisbane, Melbourne, Perth, Wollongong
2025-06-15
Recruiting
Clinical Hub for Interventional Research (CHOIR)
Observational
25
Canberra, Sydney, Westmead
2025-06-06
Recruiting
Celgene
Phase 2
200
Newcastle, Sydney, Kent Town, Hobart, Box Hill, Heidelberg, Parkville, Nedlands
2025-06-05
Recruiting
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
NCT06891443Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Sensation Disorders
DrugSepofarsen
Laboratoires Thea
Phase 3
32
Sydney
2025-06-04
Recruiting
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
NCT07063875Uveal Melanoma, Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver
DrugAldesleukin
St Vincent's Hospital, Sydney
Phase 1/2
8
Sydney, Melbourne
2025-06-01
Recruiting
The University of New South Wales
Not applicable
60
Sydney
2025-06-01
Not yet open
Rehabilitation in the Home After Hip Fracture
NCT06980129Hip Fractures (ICD-10 72.01-72.2), Rehabilitation Program
South West Sydney Local Health District
Not applicable
220
Sydney
2025-06-01
Recruiting
Design Therapeutics, Inc.
Phase 1/2
20
Sydney, East Melbourne, Melbourne
2025-06
Recruiting
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
Phase 1
12
Sydney
2025-05-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Sydney, Brisbane, Parkville
2025-05-26
Recruiting
Analysis of Long-term Outcomes of Endoscopic Resection of Duodenal and Ampullary Mucosal and Submucosal Lesions
NCT07781137Duodenal Adenoma, Duodenal Carcinoma, Papillary Adenoma, Papillary Adenocarcinoma
Western Sydney Local Health District
Observational
1,000
Sydney
2025-05-23
Active, closed
Alkermes, Inc.
Phase 2
126
Sydney, Bedford Park, Clayton
2025-05-22
Recruiting
Penumbra Inc.
Observational
300
Bedford Park, Sydney
2025-05-18
Active, closed
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
NCT06907875Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc.
Phase 1/2
12
Sydney
2025-05-08
Recruiting
CorWave LVAS FIH Study
NCT06907017Advanced Heart Failure
CorWave
Not applicable
20
Sydney, Melbourne
2025-05-06
Recruiting
Takeda
Phase 3
225
Garran, Sydney, Douglas, Adelaide, Box Hill, Fitzroy, Melbourne, Parkville
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Adelaide, Birtinya, Brisbane, Douglas, Melbourne, Perth, Sydney
2025-05-05
Recruiting
Kiora Pharmaceuticals, Inc.
Phase 2
28
Sydney, Westmead, Adelaide, Hobart, East Melbourne, Nedlands
2025-05-01
Recruiting
AbbVie
Phase 2
390
Sydney, South Brisbane, Woodville South, Heidelberg, Nedlands
2025-04-24
Recruiting
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
NCT06510699Fungal Infection, Haematological Malignancy, Blood Cancer, Infectious Disease
The University of Queensland
Phase 2
104
Sydney, Brisbane, South Brisbane, Adelaide, Melbourne
2025-04-14
Recruiting
University Health Network, Toronto
Observational
3,000
Sydney, Melbourne
2025-04-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Sydney, Brisbane, East Melbourne, Frankston
2025-04-09
Recruiting
Tissue Repair Gel in Venous Leg Ulcers in AU/US
NCT06707103Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis
DrugGlucoprime
TR Therapeutics
Phase 3
312
Camperdown, Kogarah, Orange, Sydney, Bendigo, Ivanhoe, Shepparton, Nedlands
2025-04
Recruiting
Phase 1 Study of Chlamydia Trachomatis mRNA Vaccine in Adults.
NCT06891417Chlamydia Trachomatis Immunization
Sanofi
Phase 1
80
Bruce, Maroubra, Sydney, Albion, Morayfield, Southport, Melbourne
2025-03-27
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Sydney
2025-03-26
Recruiting
Daiichi Sankyo
Phase 3
582
Adelaide, Auchenflower, Hobart, Perth, Richmond, St Leonards, Sydney, Townsville
2025-03-19
Recruiting
Hoffmann-La Roche
Phase 3
600
Garran, Sydney, Herston, South Brisbane, Woolloongabba, Adelaide, Epping, Murdoch
2025-03-17
Active, closed
Hoffmann-La Roche
Phase 4
274
Strathfield, Sydney, Adelaide, East Melbourne, Rowville, Nedlands
2025-03-14
Recruiting
Neurotech Pharmaceuticals
Phase 3
60
East Melbourne, Perth, Sydney
2025-03-06
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Melbourne, Canberra, North Sydney, Perth, Sydney
2025-03-01
Not yet open
Neonatologist-Performed Lung Ultrasound (NPLUS) to Guide Respiratory Therapy
NCT06901206PreTerm Neonate, Respiratory Distress Syndrome (RDS)
Royal Hospital For Women
Not applicable
20
Sydney
2025-03
Recruiting
Incyte Corporation
Phase 3
600
Charleston, Kogarah, Liverpool, Sydney, Woolloongabba, Melbourne, Fremantle, Westmead
2025-02-28
Recruiting
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
NCT06763055Intracerebral Hemorrhage, Spontaneous Intracerebral Hemorrhage, Supratentorial Intracerebral Haemorrhage, Acute Intracerebral Haemorrhage
DrugColchicine
The George Institute
Phase 3
2,000
Sydney
2025-02-27
Recruiting
University of Auckland, New Zealand
Observational
125
Sydney
2025-02-26
Recruiting
CStone Pharmaceuticals
Phase 1/2
800
Melbourne, South Brisbane, Sydney
2025-02-24
Active, closed
Gilead Sciences
Phase 2
39
Sydney, Kurralta Park, Clayton, Melbourne
2025-02-18
Recruiting
Bayer
Phase 2
111
Blacktown, Sydney, Southport
2025-02-13
Active, closed
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd
Phase 2
100
Albury, Hurstville, Parramatta, Sydney, Westmead, Birtinya, Adelaide
2025-02-11
By invitation
Western Sydney Local Health District
Observational
500
Sydney, Westmead, Nedlands
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Liverpool, Randwick, Saint Leonards, Sydney, Southport, Melbourne
2025-02-10
Recruiting
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1
234
Randwick, Sydney
2025-02-10
Not yet open
Woolcock Institute of Medical Research
Not applicable
558
Sydney
2025-02-01
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Box Hill, Parkville, Perth, Sydney
2025-02-01
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Phillip, Sydney, Westmead, Melbourne, Parkville
2025-01-31
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bedford Park, Kingswood, South Brisbane, Sydney
2025-01-29
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugALKS 2680
Alkermes, Inc.
Phase 2/3
786
Sydney, Bedford Park, Clayton
2025-01-27
Active, closed
AbbVie
Phase 1
4
Sydney, Southport, Heidelberg, Perth
2025-01-27
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer
DrugFamotidine
Epkin
Phase 1
146
Sydney, Perth
2025-01-23
Recruiting
Incyte Corporation
Phase 3
240
Sydney, Adelaide, Heidelberg
2025-01-21
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
100
Saint Leonards, Sydney, Tugun, Adelaide, Frankston
2025-01-21
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Sydney
2025-01-20
Active, closed
argenx
Phase 3
631
Sydney, Woodville South, Clayton, Murdoch
2025-01-15
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke
Region Skane
Phase 4
3,500
Adelaide, Clayton, Sydney
2025-01-07
Recruiting
Therini Bio Pty Ltd
Phase 1
21
Parramatta, Sydney, Westmead, Woolloongabba, Adelaide, Albans, Malvern
2024-12-20
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
NCT06656494Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
DrugsMesutoclax·Azacitidine
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
266
Sydney, Perth
2024-12-18
Active, closed
argenx
Phase 3
154
Parkville, Southport, Sydney, Woolloongabba
2024-12-18
Active, closed
Arrowhead Pharmaceuticals
Phase 1
39
Sydney, Melbourne
2024-12-17
Active, closed
Kirby Institute
Phase 3
300
Sydney, Melbourne
2024-12-16
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
186
Sydney, Wollongong, Benowa, Adelaide, Melbourne
2024-12-11
Recruiting
Basilea Pharmaceutica
Phase 3
450
Sydney, Woolloongabba, Melbourne, Parkville, Clayton
2024-12-11
Active, closed
Vicore Pharma AB
Phase 2
378
Footscray, Adelaide, Brisbane, Concord, Darlinghurst, Douglas, Heidelberg, Sydney
2024-12-09
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Camperdown, Sydney, Melbourne
2024-12-09
Active, closed
Arrowhead Pharmaceuticals
Phase 1/2
190
Camberwell, Charlestown, Maroochydore, Sydney
2024-12-04
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
386
Sydney
2024-11-18
Recruiting
University of Birmingham
Phase 1/2
160
Sydney
2024-11-11
Recruiting
Murdoch Childrens Research Institute
Phase 4
40
Melbourne, Sydney
2024-11-10
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Sydney, Melbourne, Mount Pleasant
2024-11-03
Active, closed
SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)
NCT06461286OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies, Kjer Optic Atrophy
DrugPYC-001
PYC Therapeutics
Phase 1
18
Sydney, East Melbourne
2024-10-31
Active, closed
Sydney Local Health District
Observational
50
Sydney
2024-10-30
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Sydney, Westmead, Auchenflower
2024-10-29
Recruiting
Murdoch Childrens Research Institute
Phase 2
232
Sydney, Brisbane, Melbourne, Perth
2024-10-29
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 1
59
Sydney, Brisbane, Adelaide, Nedlands
2024-10-23
Active, closed
The Ladera Large Bore Closure Feasibility Study
NCT06358157Vascular Closure, Femoral Arteriotomy Closure
Ladera Medical
Not applicable
30
Sydney, Melbourne
2024-10-21
Recruiting
Jubilant Therapeutics Inc.
Phase 1/2
30
Sydney, Adelaide, Melbourne, Perth, Nedlands
2024-10-21
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
78
Sydney, Wollongong, Brisbane, Cairns, Toowoomba, Adelaide, Melbourne, Kalgoorlie-Boulder
2024-10-14
Recruiting
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
NCT06533332Advanced Solid Tumor, Metastatic Breast Cancer, Metastatic Ovarian Cancer, Metastatic Endometrial Cancer
EtiraRx Australia Pty Ltd
Phase 1
36
Ryde, Sydney, Westmead, Adelaide
2024-10-14
Recruiting
The George Institute
Not applicable
2,000
Sydney
2024-10-11
Active, closed
Incyte Corporation
Phase 3
346
Charlestown, Kogarah, Sydney, Westmead, Woolloongabba, Melbourne, Fremantle
2024-10-10
Recruiting
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic
DrugTenecteplase
University of Calgary
Phase 3
4,000
Sydney, Melbourne
2024-09-26
Recruiting
The George Institute
Phase 3
20,000
Sydney
2024-09-26
Active, closed
BioCryst Pharmaceuticals
Phase 1
76
Sydney, Brisbane
2024-09-26
Active, closed
Cerevance
Phase 3
330
Darlinghurst, Kogarah, Sydney, Woolloongabba, Cheltenham, Melbourne, Nedlands
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
East Melbourne, Strathfield, Sydney, Westmead
2024-09-19
Active, closed
Hoffmann-La Roche
Phase 3
400
Garran, Sydney, South Brisbane, Adelaide, Murdoch
2024-09-17
Active, closed
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Priovant Therapeutics, Inc.
Phase 3
371
Sydney, East Melbourne, Nedlands
2024-09-11
Active, closed
Tectonic Therapeutic
Phase 2
191
Camperdown, Macquarie, New Lambton, Sydney, Wollongong, Chermside, Hobart, Malvern
2024-09-04
Recruiting
Study With [225Ac]Ac-FL-020 in mCRPC Participants
NCT06492122Metastatic Castration-resistant Prostate Cancer
DrugBlood samples for PK
Full-Life Technologies UK Limited
Phase 1
50
Brisbane, Murdoch, Sydney
2024-08-30
Active, closed
Sanofi
Phase 2
229
Sydney, Mackay, Melbourne
2024-08-29
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals
Phase 1/2
54
Concord, Sydney, Birtinya
2024-08-28
Recruiting
Merit Medical Systems, Inc.
Observational
100
Brisbane, Sydney
2024-08-22
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Camperdown, Sydney, Melbourne
2024-08-19
Active, closed
Medinol Ltd.
Not applicable
30
Melbourne, Perth, Sydney
2024-08-15
Active, closed
Uniquity One (UNI)
Phase 2
182
Taringa, Coffs Harbour, Sydney, Tarragindi
2024-08-14
Active, closed
Genmab
Phase 3
379
Garran, Sydney, Wollongong, Toowoomba, Clayton, Perth
2024-08-13
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Sydney, Albury, Parramatta
2024-08-07
Active, closed
GlaxoSmithKline
Phase 3
10,212
Botany, Coffs Harbour, Sydney, Taringa, Tarragindi, Camberwell, Geelong, Spearwood
2024-08-01
Recruiting
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
NCT06278857Endometrial Cancer Stage I, Mmr Deficiency, Endometrioid Endometrial Adenocarcinoma, Immune-related Adverse Event
DrugDostarlimab
Queensland Centre for Gynaecological Cancer
Phase 2
10
Sydney, Brisbane, Melbourne
2024-08-01
Active, closed
Annexon, Inc.
Phase 3
659
Albury, Parramatta, Strathfield, Sydney
2024-07-30
Active, closed
Spinogenix
Phase 2
24
Sydney, Adelaide
2024-07-29
Recruiting
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
520
Sydney, Wollongong, Melbourne, Perth, Brisbane, East Maitland, Heidelberg, Malvern
2024-07-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Sydney, Herston, Clayton, Melbourne, Nedlands
2024-07-24
Recruiting
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
NCT06208657Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Recurrent Cancer
DrugsPaxalisib·Opdualag·Temozolomide·Irinotecan
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2
90
Newcastle, Sydney, Brisbane, Adelaide, Hobart, Melbourne, Perth
2024-07-10
Active, closed
Amgen
Phase 3
89
Sydney, Wooloongabba, Adelaie, East Melbourne
2024-07-05
Recruiting
Myeloid Therapeutics
Phase 1
70
Sydney, Woolloongabba, Melbourne, Murdoch
2024-07-01
Active, closed
Genmab
Phase 3
621
Darlinghurst, Herston, Melbourne, Nedlands, Saint Leonards, Sydney
2024-06-25
Active, closed
Celgene
Phase 3
850
Gosford, Sydney, Westmead, Tiwi, Birtinya, Southport, Frankston, Heidelberg
2024-06-19
Recruiting
CTNNB1 Neurodevelopmental Syndrome - Natural History Study
NCT07167732CTNNB1 Neurodevelopmental Syndrome
University Medical Centre Ljubljana
Observational
250
Sydney
2024-06-14
Recruiting
University of Sydney
Not applicable
400
Sydney, Brisbane, Melbourne
2024-06-03
Recruiting
Eli Lilly and Company
Phase 3
300
Adelaide, Coorparoo, Perth, Sydney
2024-06-03
Recruiting
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
NCT05892510Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder, Central Nervous System Diseases
University of Melbourne
Phase 2/3
462
Gold Coast, Adelaide, Melbourne, Perth, Sydney, Townsville
2024-06-01
Active, closed
Avecho Biotechnology
Phase 3
519
North Sydney, Sydney, Southport, Clayton, Nedlands
2024-05-16
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Sydney
2024-05-15
Recruiting
W.L.Gore & Associates
Observational
2,000
New Lambton Heights, Southport, Bedford Park, Melbourne, Perth, Sydney
2024-05-07
Recruiting
University of Birmingham
Phase 2/3
210
Sydney, Brisbane, Perth
2024-05-02
Recruiting
BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation
NCT05959252Extracorporeal Membrane Oxygenation Complication
DrugsBivalirudin·Unfractionated heparin·Heparin
Sydney Local Health District
Phase 2
80
Sydney
2024-05-01
Recruiting
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
NCT06164730Heterozygous Familial Hypercholesterolemia, Premature Coronary Heart Disease
DrugVERVE-102
Verve Therapeutics, Inc.
Phase 1
85
Adelaide, Melbourne, Sydney
2024-04-30
Recruiting
CSL Behring
Phase 2/3
3,110
Saint Leonards, Sydney, Cairns, Nambour, Woolloongabba, Clayton, St Albans, Bundaberg
2024-04-27
Active, closed
Bristol-Myers Squibb
Phase 3
44
Sydney, Clayton
2024-04-17
Active, closed
GlaxoSmithKline
Phase 4
1,358
Bruce, Blacktown, Coffs Harbour, Kanwal, Sydney, Brisbane, Osborne Park, Spearwood
2024-04-16
Active, closed
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency
NCT06255782Ornithine Transcarbamylase Deficiency, Ornithine Transcarbamylase Deficiency Disease, Ornithine Carbamoyltransferase Deficiency (Disorder), Urea Cycle Disorders, Inborn
iECURE, Inc.
Phase 3
20
Sydney, Melbourne
2024-04-08
Recruiting
Sanofi Pasteur, a Sanofi Company
Phase 1/2
800
Phillip, Kotara, Sydney, Waitara, Woolloongabba, Carlton, Melbourne
2024-04-05
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
398
Camperdown, Kingswood, New Lambton, Sydney, Westmead, Nedlands, Brisbane, Footscray
2024-04-03
Active, closed
Takeda
Phase 2
213
Sydney, South Brisbane, Bedford Park, Woodville, Melbourne, Nedlands, Perth, Murdoch
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Sydney, South Brisbane, Woolloongabba, Woodville, Clayton, Epping, Fitzroy, Footscray
2024-03-27
Recruiting
The Osteoarthritis Prevention Study
NCT05946044Osteoarthritis, Knee
Wake Forest University
Not applicable
1,230
Sydney
2024-03-21
Active, closed
Beacon Therapeutics
Phase 2/3
85
Sydney, East Melbourne
2024-03-14
Active, closed
Ryme Medical TLD Pilot Study
NCT05967091Chronic Obstructive Pulmonary Disease
Ryme Medical, Inc.
Not applicable
60
Melbourne, Sydney
2024-03-06
Recruiting
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma
DrugsHMBD-001·Cetuximab·Docetaxel
Hummingbird Bioscience
Phase 1/2
398
Sydney, Westmead, Brisbane, Greenslopes, Adelaide, Frankston, Malvern, Perth
2024-02-05
Active, closed
DualityBio Inc.
Phase 3
541
Camperdown, Kingswood, Liverpool, Sydney, Birtinya, South Brisbane, Southport, Townsville
2024-01-18
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Kogarah, Sydney, Brisbane, Murdoch
2024-01-11
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Albury, Liverpool, Parramatta, Strathfield, Sydney, Adelaide, Hobart, East Melbourne
2024-01-09
Recruiting
IO Biotech
Phase 2
60
Sydney, Melbourne
2023-12-21
Recruiting
Clarity Pharmaceuticals Ltd
Phase 3
383
Sydney, Woolloongabba, Murdoch, Nedlands
2023-12-21
Recruiting
Janssen Research & Development, LLC
Phase 3
120
South Brisbane, Sydney
2023-12-20
Active, closed
AstraZeneca
Phase 2
108
Heidelberg, Kogarah, Nedlands, Sydney
2023-12-13
Active, closed
VividWhite Pty Ltd
Not applicable
65
Sydney, Bedford Park, Doncaster East, East Melbourne, Fitzroy, Vermont South
2023-12-12
Recruiting
Eikon Therapeutics
Phase 1/2
156
Randwick, South Brisbane, Southport, Sydney, Woolloongabba, Frankston
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
St Leonards, Sydney, Brisbane, East Melbourne, Frankston
2023-12-06
Recruiting
Perminder Sachdev
Observational
300
Newcastle, Sydney, Brisbane, Melbourne
2023-11-25
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Sydney, Brisbane
2023-11-24
Recruiting
Multitude Therapeutics (Australia) Pty Ltd
Phase 1
54
Sydney, Brisbane, Adelaide, Malvern, Melbourne
2023-11-06
Active, closed
IDEAYA Biosciences
Phase 2/3
420
Sydney, Brisbane, Melbourne, Perth, Adelaide
2023-10-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Kingswood, Sydney, Brisbane, Adelaide, Clayton, Melbourne
2023-10-25
Active, closed
AstraZeneca
Phase 3
895
Clayton, Fitzroy, Heidelberg, South Brisbane, Sydney
2023-10-24
Recruiting
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NCT05814094Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication, Disability Physical, Cognitive Ability, General
Australian and New Zealand Intensive Care Research Centre
Not applicable
120
Camperdown, Sydney
2023-09-20
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1
128
Sydney, Malvern
2023-09-19
Recruiting
IKS014 in Advanced Solid Tumors That Express HER2
NCT05872295Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Iksuda Therapeutics Ltd.
Phase 1
165
Concord, Sydney, Westmead, Frankston, Melbourne, Nedlands
2023-09-14
Active, closed
Cochlear
Not applicable
150
Melbourne E., Sydney, Carlton
2023-09-11
Active, closed
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
NCT05919537Non-Small Cell Lung Cancer, Pancreatic Cancer, Locally Advanced Solid Tumor, Metastatic Solid Tumor
DrugsHMBD-001·Nab-paclitaxel·Docetaxel·Gemcitabine
Hummingbird Bioscience
Phase 1
68
Sydney, Brisbane, Adelaide, Malvern, Perth
2023-09-06
Recruiting
Ipsen
Phase 3
276
Birtinya, Footscray, Kingswood, Melbourne, Sydney, Westmead
2023-08-31
Active, closed
Pfizer
Phase 2
507
Sydney, Box Hill, East Melbourne, Fremantle
2023-08-22
Recruiting
A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
NCT05325008BK Viremia, Kidney Transplant Infection, Kidney Transplant Failure and Rejection
DrugImmunoglobulin
The University of Queensland
Phase 3
280
Canberra, New Lambton Heights, Randwick, Sydney, Westmead, Brisbane, Townsville, Woolloongabba
2023-08-18
Active, closed
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU
Helsinki University Central Hospital
Not applicable
3,500
Brisbane, Kingswood, Liverpool, Melbourne, Sydney
2023-08-17
Recruiting
DualityBio Inc.
Phase 1/2
862
Blacktown, Camperdown, Concord, New Lambton Heights, Sydney, Waratah, Birtinya, Brisbane
2023-08-17
Recruiting
Oticara Australia PTY LTD
Phase 2
24
Sydney, Brisbane, Adelaide, Perth
2023-08-17
Active, closed
Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation
NCT05564754Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain
Region Skane
Not applicable
3,500
Kingswood, Liverpool, Sydney, Brisbane, Melbourne
2023-08-17
Recruiting
The George Institute
Not applicable
70
Sydney
2023-08-02
Recruiting
University of Sydney
Phase 3
300
Sydney, Brisbane, Melbourne, Perth
2023-08-02
Recruiting
Stepcare Extended Follow-up Substudy
NCT06207942Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain, Cognitive Impairment, Caregiver Burden
Region Skane
Not applicable
600
Brisbane, Caringbah, Chermside, Kingswood, Kogarah, Liverpool, Melbourne, Sydney
2023-08-01
Recruiting
AMT-116 in Patients With Advanced Solid Tumors
NCT05725291Advanced Solid Tumor
DrugAMT-116
Multitude Therapeutics Inc.
Phase 1
80
Sydney, Brisbane, Adelaide, Victoria Park
2023-07-25
Recruiting
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
NCT04289571Cone-Rod Degeneration, Rod-Cone Degeneration
National Eye Institute (NEI)
Phase 1
165
Sydney
2023-07-25
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2
120
Sydney, Melbourne, Subiaco
2023-07-05
Active, closed
IDEAYA Biosciences
Phase 2
160
Sydney, Melbourne
2023-07-03
Recruiting
DynamiCure Biotechnology
Phase 1
320
Randwick, Sydney, Buderim, Bedford Park, Woodville South, Clayton, Malvern, Nedlands
2023-06-28
Active, closed
Phase 1/2 Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
NCT06087458Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular AMD, Non-neovascular Age-related Macular Degeneration
DrugVOY-101
Perceive Biotherapeutics, Inc.
Phase 1/2
60
Sydney, East Melbourne
2023-06-21
Active, closed
Neurogene Inc.
Phase 3
33
Sydney
2023-06-13
By invitation
Transition of Care in Type 1 Diabetes Mellitus
NCT06113588Transition, Type 1 Diabetes Mellitus
Northern Sydney and Central Coast Area Health Service
Observational
80
Sydney
2023-06-09
Active, closed
10°C vs 4°C Lung Preservation RCT
NCT05898776Lung Transplant, Organ Preservation
University Health Network, Toronto
Not applicable
317
Sydney
2023-06-09
Active, closed
Gilead Sciences
Phase 2
83
Darlinghurst, Sydney, Melbourne
2023-05-15
Active, closed
Servier Affaires Médicales
Phase 3
299
Brisbane, Fitzroy, Subiaco, Sydney, Woodville
2023-05-03
Recruiting
Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
NCT05698277Congenital Heart Defect, Cardiac Function
Anna Erenbourg
Observational
495
Sydney
2023-05-01
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
368
Randwick, Sydney, Sunshine Coast, Clayton
2023-04-04
Active, closed
Sanofi
Phase 2
999
Kogarah, Sydney
2023-04-03
Recruiting
Eupraxia Pharmaceuticals Inc.
Phase 1/2
117
Sydney, Brisbane, Maroochydore, Adelaide, Box Hill, Epping, Melbourne, Parkville
2023-03-31
Recruiting
The University of New South Wales
Observational
230
Sydney, Kelvin Grove
2023-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
641
Darlinghurst, Sydney, Brisbane, Melbourne
2023-03-17
Recruiting
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
NCT05804331Cancer of Stomach, Oesophageal Cancer, Gastric Cancer, Gastric Adenocarcinoma
Western Sydney Local Health District
Observational
500
Sydney
2023-03-14
Recruiting
Lumara Bio Oncologics GmbH
Phase 1/2
270
Melbourne, Sydney
2023-03-14
Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT05797519Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valvular Disorders
VDyne, Inc.
Not applicable
120
Sydney, Adelaide, Brisbane, Melbourne
2023-03-01
Recruiting
Kirby Institute
Observational
40,000
Canberra, Sydney, Bowen Hills, Brisbane, Cairns, Townsville, Woodford, Adelaide
2023-02-23
Active, closed
Merck Sharp & Dohme LLC
Phase 3
553
Darlinghurst, Sydney, Brisbane, Melbourne
2023-02-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
514
Darlinghurst, Sydney, Brisbane, Melbourne
2023-02-17
Recruiting
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
NCT05427487Colorectal Cancer, Gastric Cancer, Ovarian Cancer
DrugSintilimab
ImmVirx Pty Ltd
Phase 1
70
Sydney, Adelaide, Melbourne
2023-02-17
Recruiting
University of Sydney
Phase 4
280
Sydney, Annerley, Richmond
2023-02-16
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
60
Randwick, Sydney, Brisbane, Box Hill, Heidelberg, Melbourne, Parkville
2023-02-07
Recruiting
Monash University
Phase 4
9,180
Sydney, Brisbane, Adelaide, Hobart, Melbourne, Nedlands, Perth
2023-02-07
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
Sydney
2023-01-24
Recruiting
Kirby Institute
Observational
80,000
Sydney, Aldershot, Brisbane, Cairns, Coorparoo, Ipswich, Rathdowney, Townsville
2023-01-23
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2
38
Saint Leonards, Sydney, Westmead, Herston, Adelaide, Bedford Park, Ballarat Central, Box Hill
2023-01-23
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Randwick, Sydney, Herston, Hobart, Heidelberg, Nedlands
2023-01-23
Recruiting
Eli Lilly and Company
Phase 1
677
Darlinghurst, Hunter Region, NSW, St Leonards, Sydney
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
606
Camperdown, Gosford, Port Macquarie, St Leonards, Sydney, Adelaide, Bendigo, East Melbourne
2023-01-10
By invitation
BioMarin Pharmaceutical
Observational
172
Sydney, Herston, Adelaide, Melbourne, Murdoch
2023-01-01
Active, closed
Exelixis
Phase 3
317
Albury, Camperdown, Liverpool, Macquarie, Sydney, Waratah, Douglas, Elizabeth Vale
2023-01-01
Recruiting
The George Institute
Phase 3
994
Sydney, Brisbane, Melbourne
2023-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
20
Sydney
2022-12-19
Recruiting
Precision Medicine for Every Child With Cancer
NCT05504772Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Australian & New Zealand Children's Haematology/Oncology Group
Observational
3,500
Adelaide, Brisbane, Hobart, Melbourne, Newcastle, Perth, Sydney
2022-12-16
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Clayton, Adelaide, New Lambton Heights, Parkville, Perth, South Brisbane, Sydney, Westmead
2022-12-15
Recruiting
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
NCT05636514Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia
DrugsDecitabine/Cedazuridine·Defactinib·Lumakras·Decitabine
Clinical Hub for Interventional Research (CHOIR)
Phase 1
12
Sydney, Westmead
2022-12-14
Active, closed
Amgen
Phase 3
7,297
Garran, Camperdown, Concord, Liverpool, Sydney, Wollongong, Auchenflower, Herston
2022-12-14
Recruiting
The University of Queensland
Phase 3
1,174
Gosford, Sydney, Bundaberg, Douglas, Herston, Woolloongabba, Adelaide, Melbourne
2022-11-29
Recruiting
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NCT05562505Mechanical Ventilation Complication, Hypoxemia, Acute Respiratory Distress Syndrome Due to COVID-19, COVID-19 Respiratory Infection
Australian and New Zealand Intensive Care Research Centre
Not applicable
140
Darlinghurst, Sydney, Brisbane, Gold Coast, Melbourne, Perth
2022-11-28
Recruiting
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1
54
Westmead, Sydney
2022-11-11
Active, closed
University Medical Center Groningen
Phase 3
1,750
Canberra, New Lambton Heights, Sydney, Wollongong, Birtinya, Brisbane, Douglas, Adelaide
2022-11-08
Active, closed
QBiotics Group Limited
Phase 2
15
Sydney, Brisbane
2022-11-03
Recruiting
Arcus Biosciences, Inc.
Phase 1
362
Camperdown, Melbourne, Sydney
2022-10-26
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Sydney, Frankston, Heidelberg, Warrnambool
2022-09-19
Active, closed
European Myeloma Network B.V.
Phase 3
1,594
Adelaide, Birtinya, Douglas, Geelong, Melbourne, Newcastle, Sydney
2022-09-08
Active, closed
Anthony Joshua, FRACP
Phase 1
44
Sydney
2022-09-04
Recruiting
Teligene US
Phase 2
128
Sydney, Birtinya, Subiaco
2022-09-01
Active, closed
Olema Pharmaceuticals, Inc.
Phase 1
190
Sydney, Nedlands
2022-08-31
Recruiting
Yuhan Corporation
Phase 1/2
147
Adelaide, Melbourne, Perth, Sydney
2022-08-26
Recruiting
Amsterdam UMC, location VUmc
Not applicable
100
Sydney
2022-08-24
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
40
Sydney
2022-08-22
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bedford Park, Footscray, Kurralta Park, Liverpool, Newcastle, Southport, Sydney, Westmead
2022-08-17
Active, closed
Gilead Sciences
Phase 2/3
689
Darlinghurst, Sydney, Melbourne
2022-08-16
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
442
Sydney, Malvern, Melbourne, Nedlands, Bedford Park
2022-08-03
Recruiting
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
NCT05072314Breast Cancer, Breast Cancer Female, Breast Conserving Surgery, Mastectomy
DrugLidocaine
Monash University
Phase 3
4,300
Kingswood, Mount Druitt, Sydney, Brisbane, Coopers Plains, Mackay, Rockhampton, Southport
2022-07-27
Active, closed
Preventing Cognitive Decline with Metformin
NCT04511416Cognitive Decline
Garvan Institute of Medical Research
Phase 3
242
Sydney
2022-07-15
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 1/2
35
Sydney, Melbourne
2022-07-14
Active, closed
Phase III Trial of Sirolimus in IBM
NCT04789070Inclusion Body Myositis
DrugsRapamycin·Sirolimus
University of Kansas Medical Center
Phase 3
140
Sydney, Brisbane, Adelaide, Melbourne, Perth
2022-07-01
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
East Melbourne, Albury, Sydney, Bendigo, St Albans
2022-06-30
Recruiting
BioNTech SE
Phase 1
320
Randwick, Sydney, Adelaide, Clayton
2022-06-17
Recruiting
Nuvalent Inc.
Phase 1/2
840
Sydney, Woolloongabba, Melbourne
2022-06-09
Recruiting
Antengene Therapeutics Limited
Phase 1
98
Sydney, Benowa, Bedford Park, Frankston, Mount Pleasant
2022-06-07
Recruiting
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
NCT05320198Myelofibrosis; Anemia, Anemia, Myelofibrosis, Myelofibrosis Due to and Following Polycythemia Vera
DrugDISC-0974
Disc Medicine, Inc
Phase 1/2
150
Nedlands, Saint Albans, Sydney, West Perth
2022-06-06
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Brisbane, Melbourne, Sydney
2022-05-30
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
83
Gosford, Liverpool, Randwick, St Leonards, Sydney, Westmead, Southport, Frankston
2022-05-30
Active, closed
Genentech, Inc.
Observational
400
Parramatta, Sydney, Adelaide, East Melbourne, Nedlands
2022-05-27
Recruiting
Post Market Clinical Follow up of ResMed Mask Systems
NCT05262439Obstructive Sleep Apnea
ResMed
Not applicable
500
Sydney
2022-05-26
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2
20
Sydney, Wollongong, Melbourne
2022-05-20
Active, closed
Eli Lilly and Company
Phase 1
260
Adelaide, East Melbourne, Sydney
2022-05-11
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Alexandria, St Leonards, Sydney, Brisbane, South Brisbane, Frankston, Elizabeth Vale
2022-05-03
Active, closed
Pierre Fabre Medicament
Phase 3
815
Sydney, Wollstonecraft, Woolloongabba, North Adelaide, Box Hill, Heidelberg, Prahran, Nedlands
2022-05-02
Active, closed
AO Innovation Translation Center
Observational
1,000
Brisbane, Sydney
2022-04-05
Recruiting
ORIC Pharmaceuticals
Phase 1/2
350
Camperdown, Melbourne, Nedlands, Sydney
2022-03-10
Active, closed
The George Institute
Phase 3
190
Sydney
2022-03-10
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 3
660
Sydney, Brisbane, Adelaide, Melbourne
2022-03-02
Recruiting
Kirby Institute
Observational
10,000
Sydney, Darwin, Birtinya, Cairns, Adelaide, Melbourne, Albany, Broome
2022-02-17
Recruiting
DualityBio Inc.
Phase 1/2
796
Randwick, Sydney, South Brisbane, Melbourne
2022-01-31
Active, closed
OncoBeta Therapeutics
Not applicable
210
Sydney, Tugun, Perth
2022-01-17
Recruiting
Zimmer Biomet
Observational
167
Sydney, Bedford Park, Melbourne
2022-01-02
Active, closed
Trans Tasman Radiation Oncology Group
Phase 2
35
Sydney, Brisbane, Melbourne
2022-01-01
Active, closed
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
NCT05218668Amyotrophic Lateral Sclerosis
DrugFasudil
Woolsey Pharmaceuticals
Phase 2
40
Sydney, Brisbane, Melbourne
2021-12-22
Active, closed
Smith & Nephew, Inc.
Observational
299
Sydney, Windsor
2021-12-21
Recruiting
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
NCT05136222Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Melbourne
Not applicable
244
Adelaide, Brisbane, Canberra, Melbourne, Perth, Sydney
2021-12-15
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Albury, Birtinya, Brisbane, Saint Leonards, Sydney
2021-12-14
Recruiting
Relay Therapeutics, Inc.
Phase 1
930
Sydney, Melbourne
2021-12-08
Recruiting
Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer
NCT04676828Lung Cancer, Radiation-Induced Disorder, Radiation Pneumonitis, Pulmonary Disease
University of Aarhus
Not applicable
90
Sydney
2021-12-01
Recruiting
University of Melbourne
Phase 2/3
688
Bankstown, Newcastle, Sydney, Gold Coast, Woolloongabba, Adelaide, Melbourne, Murdoch
2021-11-29
Recruiting
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
NCT05005026Spinal Cord Injuries, Neuropathic Pain
Texas A&M University
Not applicable
250
Sydney
2021-11-23
Active, closed
Kite, A Gilead Company
Phase 1/2
247
St Leonards, Sydney, Adelaide, Clayton, East Melbourne, Fitzroy
2021-10-27
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
1,000
Bankstown, Camperdown, Kingswood, New Lambton Heights, Port Macquarie, Sydney, Tamworth, Westmead
2021-10-26
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
NCT05009992Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27M-Mutant
DrugsDNX-2401·Dordaviprone·Paxalisib
University of California, San Francisco
Phase 2
360
New Lambton Heights, Westmead, South Brisbane, Clayton, Melbourne, Nedlands, Adelaide, Sydney
2021-10-20
Active, closed
Bioventus LLC
Phase 2
210
Botany, Broadmeadow, Saint Leonards, Sydney, Camberwell
2021-09-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Darlinghurst, Sydney, Murdock
2021-09-15
Active, closed
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
DrugsKeytruda·Pembrolizumab
Medicenna Therapeutics, Inc.
Phase 1/2
160
Randwick, Sydney, Buderim, Greenslopes
2021-08-27
Active, closed
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
NCT05020678Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma
DrugNKX019
Nkarta, Inc.
Phase 1
150
Camperdown, Sydney, Brisbane, Melbourne
2021-08-20
Active, closed
The Cryopreserved vs. Liquid Platelets Trial
NCT03991481Surgical Blood Loss, Hemorrhage
Australian and New Zealand Intensive Care Research Centre
Phase 3
388
Sydney, Brisbane, Douglas, Southport, Fitzroy, Heidelberg
2021-08-17
Active, closed
Combination Immunotherapy in Rare Cancers Under InvesTigation
NCT04969887Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Neoplasm, MSI-H Solid Malignant Tumor
DrugsYervoy·Ipilimumab·Opdivo·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
240
Albury, Orange, Sydney, Waratah, Cairns, Douglas, Townsville, Adelaide
2021-08-03
Active, closed
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
NCT04956640Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Ovarian Neoplasms
DrugsOlomorasib·Erbitux·Cetuximab·Pemetrexed
Eli Lilly and Company
Phase 1/2
540
St Leonards, Sydney, Adelaide, Frankston, Nedlands
2021-07-19
Recruiting
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
NCT05024929Papillary Thyroid Cancer, Pediatric Cancer, Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
Observational
32
Sydney
2021-07-16
Recruiting
Australian and New Zealand Intensive Care Research Centre
Phase 2
450
Sydney, Wollongong, Birtinya, Brisbane, Southport, Adelaide, Geelong, Melbourne
2021-07-15
Active, closed
Hoffmann-La Roche
Phase 3
451
Albury, Hurstville, Liverpool, Miranda, Sydney, Woolloongabba, East Melbourne, Rowville
2021-07-14
Active, closed
Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
NCT04788888Symptomatic Severe Aortic Stenosis
Abbott Medical Devices
Not applicable
434
Murdoch, Sydney, Woolloongabba, Adelaide, Melbourne, Ryde
2021-07-13
Active, closed
The Netherlands Cancer Institute
Phase 3
423
Sydney, Brisbane, Gateshead, Melbourne, Murdoch, Southport
2021-07-08
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Heidelberg, Nedlands, Sydney
2021-07-08
Active, closed
Kirby Institute
Phase 3
650
Parramatta, Sydney, Southport, Carlton, Melbourne
2021-07-08
Recruiting
HighLife SAS
Not applicable
30
Auchenflower, Perth, Sydney
2021-07-01
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Gosford, Liverpool, Saint Leonards, Sydney, Gateshead, Melbourne
2021-06-17
Recruiting
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT04889924Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection
Hospital Universitari de Bellvitge
Not applicable
820
Sydney
2021-06-11
Recruiting
Personalised Immunotherapy Platform
NCT06536257Melanoma, Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma
Melanoma Institute Australia
Observational
1,000
Sydney
2021-06-08
Recruiting
Nutrition in Paediatric Critical Care
NCT06695078ICU, Nutrition, Paediatric
Australian and New Zealand Intensive Care Research Centre
Observational
200
Adelaide, Brisbane, Hobart, Melbourne, Perth, Sunshine Coast, Sydney
2021-06-07
Recruiting
BonE and Joint Infections - Simplifying Treatment in Children Trial
NCT04538053Bone Infection, Septic Arthritis, Bone and Joint Infection, Osteomyelitis
DrugCefazolin
Murdoch Childrens Research Institute
Phase 4
214
Kingswood, New Lambton Heights, Sydney, Darwin, Brisbane, Adelaide, Melbourne, Perth
2021-06-01
Active, closed
Columbia University
Observational
122
Adelaide, Chatswood, East Melbourne, Maribyrnong, North Adelaide, Subiaco, Sydney
2021-05-06
Active, closed
Incyte Corporation
Phase 3
654
Kogarah, Sydney, Wollongong, Southport, Adelaide, Bedford Park, Melbourne, St Albans
2021-04-15
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Sydney, Box Hill, Nedlands
2021-04-05
Active, closed
ALX Oncology Inc.
Phase 2
189
Sydney, Brisbane, Melbourne, Perth, Windsor Gardens
2021-04-02
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Bendigo, Concord, Fitzroy, Gosford, Kurralta Park, Melbourne, St Albans, Sydney
2021-03-18
Recruiting
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
NCT04903782Neoplastic Syndromes, Hereditary, Cancer, Genetic Predisposition to Disease
Sydney Children's Hospitals Network
Observational
270
Newcastle, Sydney
2021-03-08
Active, closed
Melanoma and Skin Cancer Trials Limited
Not applicable
670
Camperdown, Newcastle, Sydney, Wollstonecraft, Brisbane, Cairns, Townsville, Bendigo
2021-03-03
Active, closed
Pauline Kang
Not applicable
72
Sydney
2021-02-11
Active, closed
Pullback Pressure Gradient (PPG) Global Registry
NCT04789317Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction
VZW Cardiovascular Research Center Aalst
Observational
982
Melbourne, Sydney
2020-12-23
Active, closed
Daiichi Sankyo
Phase 3
605
Bedford Park, Blacktown, Heidelberg, North Ryde, Sydney, Wollongong
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bedford Park, Box Hill, Sydney
2020-12-18
Recruiting
University of Melbourne
Not applicable
240
Newcastle, Sydney, Brisbane, Southport, Adelaide, Melbourne, Parkville
2020-11-15
Active, closed
Bayer
Phase 4
654
Castle Hill, Gosford, Kingswood, North Tamworth, St Leonards, Sydney, Wollongong, Brisbane
2020-11-09
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Sydney
2020-11-01
Active, closed
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
NCT04291885Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III
DrugAvelumab
Melanoma and Skin Cancer Trials Limited
Phase 2
122
Port Macquarie, Sydney, Wollongong, Brisbane, Bundaberg, Cairns, Hervey Bay, Mackay
2020-10-26
Active, closed
Exelixis
Phase 3
575
Garran, Port Macquarie, Saint Leonards, Sydney, Wollongong, Chermside, Launceston, Ballarat
2020-10-19
Active, closed
Targeted Therapy and Avelumab in Merkel Cell Carcinoma
NCT04261855Metastatic Merkel Cell Carcinoma
DrugAvelumab
Melanoma and Skin Cancer Trials Limited
Phase 1/2
19
Coffs Harbour, Gateshead, Gosford, Hamlyn Terrace, Sydney, Brisbane, Adelaide, Melbourne
2020-10-08
Active, closed
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
NCT04323046Glioblastoma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Malignant Glioma
DrugsOpdivo·Nivolumab
Sabine Mueller, MD, PhD
Phase 1
9
Sydney, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2020-10-02
Recruiting
Efemoral Medical, Inc.
Not applicable
100
Sydney, Canberra, Melbourne
2020-09-22
Recruiting
University of Birmingham
Phase 1/2
1,672
Brisbane, Camperdown, Clayton, Melbourne, New Lambton Heights, Perth, Sydney, Westmead
2020-09-17
Active, closed
RSA Masterloc Study Australia
NCT05818878Radiostereometric Analysis
Medacta International SA
Observational
26
Sydney
2020-09-01
Recruiting
Morten H. Bestle
Phase 4
1,000
Sydney
2020-08-17
Active, closed
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
162
Camperdown, Darlinghurst, Kogarah, Liverpool, Macquarie Park, Newcastle, Sydney, Brisbane
2020-08-17
Active, closed
Eli Lilly and Company
Phase 3
996
Concord, Sydney, Brisbane, Maroochydore, Adelaide, Parkville, Murdoch
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,736
Erina, Sydney, Carlton, Glen Iris, Malvern, Melbourne, Parkville
2020-06-19
Recruiting
International CIPN Assessment and Validation Study
NCT04633655Chemotherapy-induced Peripheral Neuropathy, Quality of Life
University of Milano Bicocca
Observational
1,000
Sydney
2020-06-08
Active, closed
AstraZeneca
Phase 3
805
Clayton, Malvern, Melbourne, Nedlands, Sydney
2020-05-05
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 2
130
Liverpool, St Leonards, Sydney, Brisbane, Adelaide, Malvern, Melbourne, Prahran
2020-04-21
Active, closed
University of Sydney
Phase 3
1,100
Albury, Gosford, Newcastle, Nowra, Sydney, Wollongong, Brisbane, Herston
2020-03-31
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Sydney, Brisbane, Adelaide, Melbourne, Richmon, St Albans, Perth
2020-03-01
By invitation
The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
NCT05298982Critically Ill, Mechanical Ventilation, Long Term Outcome
Australian and New Zealand Intensive Care Research Centre
Observational
250
Camperdown, Sydney, Wollongong, Birtinya, Brisbane, Caboolture, Redcliffe, Toowoomba
2020-02-11
Recruiting
Kirby Institute
Phase 4
30
Darlinghurst, Sydney, Adelaide
2020-02-11
Recruiting
Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
NCT06401304Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Invasive, Breast Asymmetry
Uppsala University
Observational
1,200
Sydney
2020-01-01
Recruiting
Melanoma and Skin Cancer Trials Limited
Not applicable
2,998
Bruce, Garran, Sydney, Brisbane, Gold Coast, Adelaide, Melbourne
2019-12-17
Active, closed
Auckland City Hospital
Not applicable
550
Sydney, Southport, Woolloongabba
2019-11-28
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Sydney, Clayton, Nedlands, New Lambton Heights, Westmead
2019-11-05
Active, closed
Bristol-Myers Squibb
Phase 3
461
Sydney, Heidelberg, Melbourne, North Ballarat
2019-11-05
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Camperdown, Darlinghurst, Sydney, Chermside, Woolloongabba, Hobart, Fitzroy, Melbourne
2019-09-23
Active, closed
University Hospital Birmingham NHS Foundation Trust
Not applicable
169
Sydney
2019-09-18
Active, closed
Sanofi
Observational
1,860
Kogarah, Sydney, Melbourne, Parkville, Richmond
2019-08-15
Recruiting
Melanoma Institute Australia
Phase 2
218
Sydney, Waratah, Wollstonecraft, Woolloongabba, Adelaide, East Melbourne, Melbourne, Perth
2019-08-14
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Coffs Harbour, North Sydney, Sydney, Waratah, Westmead, Greenslopes, South Brisbane, Southport
2019-08-09
Recruiting
Centers for Disease Control and Prevention
Phase 2/3
3,400
Sydney
2019-08-01
Active, closed
177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT03874884Metastatic Castration Resistant Prostate Cancer (mCRPC)
DrugOlaparib
Peter MacCallum Cancer Centre, Australia
Phase 1
70
Sydney, Melbourne
2019-07-09
Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
NCT03947385Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer, Other Solid Tumors
DrugsDarovasertib·Binimetinib·Crizotinib
IDEAYA Biosciences
Phase 1/2
336
Sydney, Woolloongabba
2019-06-28
Active, closed
Exelixis
Phase 3
855
Albury, Kogarah, North Ryde, Sydney, South Brisbane, Woolloongabba, Adelaide, North Adelaide
2019-06-25
Recruiting
HighLife SAS
Not applicable
120
Darlinghurst, Newcastle, Sydney, Auchenflower, Adelaide, Brisbane, Heidelberg, Melbourne
2019-05-28
Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
NCT03808922Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19
Ansun Biopharma, Inc.
Phase 3
274
Sydney
2019-05-23
Active, closed
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763Acute Respiratory Distress Syndrome in Children
University of Pennsylvania
Not applicable
600
Perth, Sydney
2019-05-01
By invitation
University of Edinburgh
Observational
287
Geelong, Nedlands, Newcastle, Sydney, Toowoomba
2019-04-05
Recruiting
The EXCEL Registry of Patients Requiring ECMO
NCT03793257Critically Ill, Acute Respiratory Failure, Acute Heart Failure, Cardiac Arrest
Australian and New Zealand Intensive Care Research Centre
Observational
3,000
Canberra, Camperdown, Darlinghurst, Liverpool, Newcastle, St Leonards, Sydney, Westmead
2019-02-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Camperdown, Sydney, South Brisbane, Frankston, Melbourne
2018-12-27
Active, closed
Zynerba Pharmaceuticals, Inc.
Phase 2/3
476
Sydney, Brisbane, Melbourne
2018-11-09
Active, closed
Spark Therapeutics, Inc.
Observational
29
Sydney, Melbourne
2018-08-14
Recruiting
Bipolar Androgen Therapy + Carboplatin in mCRPC
NCT03522064Castration-resistant Prostate Cancer, Homologous Recombination Deficiency
DrugTestosterone Enanthate
St Vincent's Hospital, Sydney
Phase 2
30
Sydney
2018-07-30
Recruiting
Martin Schrappe
Phase 3
5,000
Sydney, Westmead
2018-07-15
Active, closed
pharmaand GmbH
Phase 3
1,097
New Lambton Heights, Saint Leonards, Sydney, Westmead, Brisbane, Toorak Gardens, Melbourne, Subiaco
2018-05-14
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Canberra, Elizabeth Vale, Liverpool, Sydney, Westmead
2018-05-14
Active, closed
Kirby Institute
Observational
446
Darlinghurst, Sydney, Melbourne
2017-12-05
Active, closed
Melanoma Institute Australia
Phase 2
60
Sydney, Wollstonecraft, Melbourne
2017-11-08
Active, closed
ViiV Healthcare
Phase 3
1,049
Darlinghurst, Sydney, Prahran
2017-10-27
Active, closed
PRecISion Medicine for Children With Cancer
NCT03336931Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Childhood Leukemia
Sydney Children's Hospitals Network
Observational
550
Newcastle, Sydney, Brisbane, Adelaide, Melbourne, Perth
2017-09-05
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Sydney, Nedlands
2017-08-23
Recruiting
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NCT03222635Submucosal Esophageal Adenocarcinoma, Barrett Esophagus, High-risk Mucosal Esophageal Adenocarcinoma
Amsterdam UMC
Not applicable
225
Sydney
2017-07-25
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Herston, Darlinghurst, Sydney, Cleveland, Woolloongabba, Box Hill, Melbourne, Mount Waverley
2017-07-21
Active, closed
Eli Lilly and Company
Phase 3
5,637
Camperdown, Darlinghurst, Lismore, Liverpool, Sydney, Waratah, Westmead, Wollongong
2017-07-12
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Sydney, Melbourne, Perth
2017-06-26
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Kogarah, Sydney, Woolloongabba, Bedford Park, Ballarat, Box Hill, Clayton, Fitzroy
2017-05-22
Active, closed
REDUCE LAP-HFREF TRIAL
NCT03093961Heart Failure
Corvia Medical
Not applicable
10
New Lambton Heights, Sydney
2017-03-10
Active, closed
DBV Technologies
Phase 3
300
Brisbane, Perth, Sydney
2017-01-23
Active, closed
Eli Lilly and Company
Phase 1
223
Newcastle, Sydney, Greenslopes
2016-11-21
Active, closed
ViiV Healthcare
Phase 3
618
Darlinghurst, Sydney, Prahran
2016-10-28
Recruiting
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
NCT04005976Aortic Aneurysm, Aortic Dissection, Aortic Diseases
The University of Texas Health Science Center, Houston
Observational
5,000
Sydney
2016-06-15
Active, closed
University of Birmingham
Phase 3
700
Adelaide, Brisbane, Melbourne, New Lambton Heights, Perth, Sydney, Westmead
2016-04
Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
NCT05169333Cardiovascular Diseases, Cardiovascular Risk Factors
University of Oxford
Observational
250,000
Sydney
2016-02-23
Rows per page Showing 1–500 of 520
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-australia/city/sydney

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,370 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 520 of those studies with a site in Sydney.

How many clinical trials are recruiting in Sydney?

298 of the 520 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 29 have not yet opened recruitment, 182 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sydney), 520 studies
PhaseStudiesRecruitingShare
Phase 31305425%
Phase 2904917.3%
Phase 1715013.7%
Not applicable704013.5%
Observational694213.3%
Phase 1/2564110.8%
Phase 2/320143.8%
Phase 41382.5%
Early Phase 1100.2%

Most active sponsors

Lead sponsors with the most studies (Sydney)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC177
Kirby Institute104
Australian and New Zealand Intensive Care Research Centre96
Eli Lilly and Company92
Novartis Pharmaceuticals96
The George Institute97
Sanofi74
Gilead Sciences62
Incyte Corporation64
Peter MacCallum Cancer Centre, Australia61
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.